Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026)
Sintx Technologies' (SINT) quarterly Cash from Investing Activities came in at -$7000.0 in Q1 2026, up 88.89% year-on-year from -$3705.9 in Q1 2025, and up 83.33% quarter-over-quarter from -$42000.0 in Q4 2025.
Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Sintx Technologies' Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$7000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 88.89% year-over-year to -$7000.0 in Q1 2026; TTM through Mar 2026 was $969000.0, a 1253.57% increase from a year earlier, with the FY2025 full-year figure at $913000.0, up 570.62% from the prior year.
- Cash from Investing Activities improved to -$7000.0 in Q1 2026 per SINT's latest filing, from -$42000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $666000.0 in Q3 2025 and bottomed at -$510000.0 in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$64000.0 (2022), against an average of -$55625.0.
- Biggest YoY gain for Cash from Investing Activities was 2248.39% in 2025; the steepest drop was 520.0% in 2025.
- Year by year, Cash from Investing Activities stood at -$296000.0 in 2022, then surged by 79.05% to -$62000.0 in 2023, then jumped by 116.13% to $10000.0 in 2024, then tumbled by 520.0% to -$42000.0 in 2025, then soared by 83.33% to -$7000.0 in 2026.
- Per Business Quant, the three latest SINT Cash from Investing Activities figures stand at -$7000.0 (Q1 2026), -$42000.0 (Q4 2025), and $666000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | -298.50 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Sintx Technologies | 5.80 Mn | 3.91 Mn | 144,000.00 | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | 666,000.00 |
| Sep 30, 2025 | 666,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Mar 31, 2025 | -63,000.00 |
| Mar 31, 2025 | -63,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Mar 31, 2024 | -173,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Sep 30, 2023 | -105,000.00 |
| Sep 30, 2023 | -105,000.00 |